SCHEMBL16604697

SCHEMBL16604697

Cc1nc(C[C@H]2CC[C@H](C)CC2)c2nc(C)sc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16604693 0.74 CHRM4 (0.34)
SCHEMBL16604682 0.72 ADORA3 (0.33)
SCHEMBL16604685 0.71 MCHR1 (0.33)
SCHEMBL16604680 0.69
SCHEMBL16659887 0.69 USP2 (0.31)
SCHEMBL16604726 0.64 ADORA3 (0.34)
SCHEMBL24802393 0.61 ADORA3 (0.33)
SCHEMBL16604694 0.60 MCHR1 (0.39)
SCHEMBL16604690 0.60 CHRM4 (0.39)
SCHEMBL16659882 0.60 USP2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234936-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) 2023-07-27 US disclosed
US-20170035766-A1 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS INC (US) 2017-02-09 US disclosed
US-9518065-B2 IRAK inhibitors and uses thereof NIMBUS IRIS, INC. (US) 2016-12-13 US disclosed
US-20150094305-A1 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS, INC. 2015-04-02 US disclosed